Felicity Payne

Felicity Payne

Auto-generated profile, based on publicly available information

Felicity Payne

Wellcome Trust Sanger Institute, Hinxton, UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2010 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JDJosée Dupuis
Josée Dupuis
CLClaudia Langenberg
Claudia Langenberg
IPInga Prokopenko
Inga Prokopenko
RSRicha Saxena
Richa Saxena
NSNicole Soranzo
Nicole Soranzo
IBInês Barroso
Inês Barroso
The MAGIC investigators report results of a large genome-wide association study meta-analysis to identify common variants influencing fasting glucose homeostasis. They further show that several of the newly discovered loci influencing glycemic traits are also associated with risk of type 2 diabetes. Levels of circulating glucose are tightly regulated. To identify new loci influencing glycemic traits, we performed meta-analyses of 21 genome-wide association studies informative for fasting glucose, fasting insulin and indices of beta-cell function (HOMA-B) and insulin resistance (HOMA-IR) in up to 46,186 nondiabetic participants. Follow-up of 25 loci in up to 76,558 additional subjects identified 16 loci associated with fasting glucose and HOMA-B and two loci associated with fasting insulin and HOMA-IR. These include nine loci newly associated with fasting glucose (in or near ADCY5, MADD, ADRA2A, CRY2, FADS1, GLIS3, SLC2A2, PROX1 and C2CD4B) and one influencing fasting insulin and HOMA-IR (near IGF1). We also demonstrated association of ADCY5, PROX1, GCK, GCKR and DGKB-TMEM195 with type 2 diabetes. Within these loci, likely biological candidate genes influence signal transduction, cell proliferation, development, glucose-sensing and circadian regulation. Our results demonstrate that genetic studies of glycemic traits can identify type 2 diabetes risk loci, as well as loci containing gene variants that are associated with a modest elevation in glucose levels but are not associated with overt diabetes.

30 April 2003 in Nature
Verified
Journal Article
Open access
PDF file
HUHironori Ueda
Hironori Ueda
JHJoanna M. M. Howson
Joanna M. M. Howson
LELaura Esposito
Laura Esposito
JHJoanne Heward
Joanne Heward
HSHywel Snook
Hywel Snook
SGStephen C. L. Gough
Stephen C. L. Gough
Genes and mechanisms involved in common complex diseases, such as the autoimmune disorders that affect approximately 5% of the population, remain obscure. Here we identify polymorphisms of the cytotoxic T lymphocyte antigen 4 gene (CTLA4)—which encodes a vital negative regulatory molecule of the immune system—as candidates for primary determinants of risk of the common autoimmune disorders Graves' disease, autoimmune hypothyroidism and type 1 diabetes. In humans, disease susceptibility was mapped to a non-coding 6.1?kb 3′ region of CTLA4, the common allelic variation of which was correlated with lower messenger RNA levels of the soluble alternative splice form of CTLA4. In the mouse model of type 1 diabetes, susceptibility was also associated with variation in CTLA-4 gene splicing with reduced production of a splice form encoding a molecule lacking the CD80/CD86 ligand-binding domain. Genetic mapping of variants conferring a small disease risk can identify pathways in complex disorders, as exemplified by our discovery of inherited, quantitative alterations of CTLA4 contributing to autoimmune tissue destruction.

27 June 2010 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TIThe MAGIC investigators
The MAGIC investigators
BVBenjamin F Voight
Benjamin F Voight
TCThe GIANT Consortium
The GIANT Consortium
LSLaura J Scott
Laura J Scott
VSValgerdur Steinthorsdottir
Valgerdur Steinthorsdottir
MMMark I McCarthy
Mark I McCarthy

30 March 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EZEleftheria Zeggini
Eleftheria Zeggini
LSLaura J. Scott
Laura J. Scott
RSRicha Saxena
Richa Saxena
BVBenjamin F. Voight
Benjamin F. Voight
JMJonathan L Marchini
Jonathan L Marchini
DADavid Altshuler
David Altshuler

6 June 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JTJohn A Todd
John A Todd
NWNeil M Walker
Neil M Walker
JCJason D Cooper
Jason D Cooper
DSDeborah J Smyth
Deborah J Smyth
KDKate Downes
Kate Downes
DCDavid G Clayton
David G Clayton

14 September 2015 in Nature
Verified
Journal Article
Open access
PDF file
TCThe UK10K Consortium
The UK10K Consortium
WGWriting group
Writing group
KWKlaudia Walter
Klaudia Walter
JMJosine L. Min
Josine L. Min
JHJie Huang
Jie Huang
WZWeihua Zhang
Weihua Zhang
The contribution of rare and low-frequency variants to human traits is largely unexplored. Here we describe insights from sequencing whole genomes (low read depth, 7×) or exomes (high read depth, 80×) of nearly 10,000 individuals from population-based and disease collections. In extensively phenotyped cohorts we characterize over 24 million novel sequence variants, generate a highly accurate imputation reference panel and identify novel alleles associated with levels of triglycerides (APOB), adiponectin (ADIPOQ) and low-density lipoprotein cholesterol (LDLR and RGAG1) from single-marker and rare variant aggregation tests. We describe population structure and functional annotation of rare and low-frequency variants, use the data to estimate the benefits of sequencing for association studies, and summarize lessons from disease-specific collections. Finally, we make available an extensive resource, including individual-level genetic and phenotypic data and web-based tools to facilitate the exploration of association results.